These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2010-024283-18||A Study to Assess the Efficacy of AF-219, a P2X3 Receptor Antagonist, in Subjects with Chronic Cough||2013-02-21||due-trials|
|Reported results||2013-003566-13||A Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Way Cross-over Study to evaluate the effect of AF-219 on methacholine hyper-reactivity in subjects with asthma.||2014-03-15||due-trials|
|Ongoing, reported early||2015-000464-34||A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects||not-yet-due|
|Ongoing, reported early||2015-000474-35||A Dose Escalation Study to Assess the Efficacy and Tolerance of||not-yet-due|
|Reported results||2015-002034-47||A Study to Assess the Effect of AF-219 on Cough Reflex Sensitivity in Both Healthy and Chronic Cough Subjects||2016-10-20||due-trials|
|Reported results||2015-005064-42||A 12-Week Study to Assess the Efficacy and Safety of AF-219 in Subjects with Treatment Refractory Chronic Cough||2016-11-04||due-trials|